ObsEva SA
(NASDAQ : OBSV)

( )
OBSV After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
ABBVAbbVie, Inc. -1.61%90.621.9%$1167.00m
JNJJohnson & Johnson 0.13%144.560.7%$1055.56m
BMYBristol-Myers Squibb Co. -0.77%60.321.0%$967.14m
MRKMerck & Co., Inc. 1.17%77.260.7%$834.37m
PFEPfizer Inc. 0.00%37.500.9%$831.66m
LLYEli Lilly & Co. -2.12%147.951.1%$423.80m
AZNAstraZeneca Plc -3.82%53.111.2%$254.16m
NVSNovartis AG 0.17%85.050.2%$156.78m
GSKGlaxoSmithKline Plc -0.37%40.740.2%$137.31m
NVONovo Nordisk A/S -2.21%63.400.1%$85.63m
SNYSanofi -0.06%47.270.2%$79.55m
RGENRepligen Corp. -4.42%133.357.1%$69.88m
ARCTArcturus Therapeutics Holdings, Inc. -6.81%54.300.0%$55.02m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 2.78%60.000.0%$45.76m
RETAReata Pharmaceuticals, Inc. -1.40%157.763.4%$37.79m

Company Profile

ObsEva SA engages in the research and development of therapeutic treatments for woman's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet in November 2012 and is headquartered in Geneva, Switzerland.